Clinical trial
A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age
The primary objective is to evaluate the efficacy of early oseltamivir treatment of influenza in children 1-3 years of age
Category | Value |
---|---|
Study start date | 2007-09-19 |